title: Minimal risk remains an open question.
authors.affiliation: University of Western Ontario, Department of Philosophy, Rotman Institute of Philosophy, Stevenson Building, London, Ontario, N68 5B8, Canada. abinik@uwo.ca
authors.forename: Ariella
authors.initials: A
authors.lastname: Binik
authors.forename: Charles
authors.initials: C
authors.lastname: Weijer
authors.forename: Mark
authors.initials: M
authors.lastname: Sheehan
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D000293:Adolescent; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000379:methods; D055812:Community-Based Participatory Research / Q000941:ethics* / Q000379:methods; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D033281:Nontherapeutic Human Experimentation / Q000941:ethics; D018579:Patient Selection / Q000941:ethics*; D011322:Primary Prevention / Q000941:ethics* / Q000379:methods; D012306:Risk; D012309:Risk-Taking
chemical_list: D016915:AIDS Vaccines